A new curious trend is emerging in the United States: more and more Americans are using cryptocurrency to purchase peptides — drugs advertised as aids for weight loss, muscle gain, and even life extension. According to my data, in the first quarter of 2026, the volume of such transactions reached $32 million, showing a staggering 700% increase compared to the same period last year.
Official peptides that have undergone clinical trials are available at pharmacy chains like Walgreens and CVS, but a huge portion of the market operates outside regulatory oversight. Cheap drugs are supplied from foreign laboratories, often without a prescription or insurance, and many packages are labeled "not for human use."
Why cryptocurrency has become indispensable
Traditional banks and payment systems refuse to service such sellers due to high compliance risks. As a result, many suppliers accept only Bitcoin. A particularly telling case is that of 49-year-old marketer Zack from the northwestern United States: to purchase retatrutide (an Eli Lilly drug) from a Chinese supplier for $240, he had to buy Bitcoin for the first time in his life. On the American market, the same purchase would have cost him $300 monthly.
Stages of explosive growth
On-chain analytics reveal three distinct stages in the evolution of this market. Until 2025, it remained a niche "underground" with a monthly inflow of about $200,000. Then the topic came to the attention of the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the U.S. Department of Health and Human Services. However, the real breakthrough occurred in late 2025, when peptides went viral in the TikTok looksmaxxing subculture. The average monthly inflow quadrupled to $9.9 million, exceeding $10 million in peak months.
Market structure: from "wild west" to professionals
The market is extremely uneven. The bulk of the volume is controlled by a narrow group of large sellers with a broad client base. The larger the supplier, the more professional their financial operations. Small players flit between different coins, while large ones almost exclusively use Bitcoin and stablecoins. Sellers with an average deposit of $1,000 or more prefer "stablecoins" to hedge currency risks in large and cross-border transactions.
Notably, according to expert data, some suppliers have moved into the peptide business from drug trafficking. China's Bigreat Technology, which previously supplied fentanyl and amphetamine precursors to Russia and Kazakhstan, has created a separate legal entity, Zhengzhou DEPU Technology, to sell cosmetic peptides.
My analysis: This phenomenon is a classic example of how cryptocurrency fills a vacuum created by excessive regulation. The U.S. peptide market is not just about tax evasion, but a systemic response to the inaccessibility of legal but expensive drugs. Here, Bitcoin acts not as a speculative asset, but as a means for cross-border trade bypassing banking infrastructure. I expect that if regulators do not offer more flexible solutions, the volume of cryptocurrency transactions in this sector will continue to grow exponentially.